NCT06360796View on ClinicalTrials.gov

Study of Pharmacokinetics and Metabolism on [(14)C]ADC189

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 24, 2023

Primary Completion Date

February 20, 2024

Study Completion Date

February 20, 2024

Conditions
PharmacokineticsMetabolism
Interventions
DRUG

[(14)C]ADC189

Each subject take a single oral dose of about 45 mg (about 100 μCi) \[(14)C\]ADC189 on Day 1 of the study, and be observed by 504 hours.

Trial Locations (1)

233004

The First Affilicated Hospital of Bengbu Medical University, Bengbu

All Listed Sponsors
lead

Jiaxing AnDiCon Biotech Co.,Ltd

INDUSTRY